Sign in
4

Changes in Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-26-062701

Chief Executive Officer sold 9,447 shares at an average $16.91 ($159,775)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Brumm Joshua T · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-16 Sale : show line 1 in the form 10b5-1 −1,610 $17.90 $28,819 279,602 D
2026-09-18 Sale : show line 2 in the form 10b5-1 −7,837 $16.71 $130,956 271,765 D
Open-market sales · 9,447 sh · avg $16.91 · $159,775
Loading xslF345X06/wk-form4_1789761722.xml…